Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer.
Authors
Von Pawel, JGatzemeier, U
Pujol, J L
Moreau, L
Bildat, S
Ranson, Malcolm R
Richardson, G
Steppert, C
Rivière, A
Camlett, I
Lane, S
Ross, G
Affiliation
Asklepios Fachklinik, Gauting bei München, Munich, Germany.Issue Date
2001-03-15